Authors/Disclosures
|
Sarah Camargos, MD
(Neurology Movement Disorder Clinic,FD)
|
No disclosure on file |
|
Alan C. Carver, MD
(Memorial Sloan Kettering Cancer Center)
|
No disclosure on file |
|
Francisco Cardoso, MD, FAAN
(UFMG)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew J. Lees, MD, FRCP
(Reta Lila Weston Institute of Neurological Studies, IoN, UCL)
|
Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Britannia. Dr. Lees has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Bial Pharma. |
|
John A. Hardy, PhD
(NIH/Lab of Neurogenetics/Institute on Aging)
|
No disclosure on file |
|
|
No disclosure on file |
|
Andrew Singleton
|
An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. |